SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Opthea Limited (OPT) , forward earnings yield 0.88%.
Criteria proven by this page:
- VALUE (10/100, Fail) — analyst consensus target implies downside from the current price ($2.00, 41.3%).
- Forward P/E 113.7
- Analyst consensus target $2.00 (-41.3% downside) — analysts see meaningful downside risk at the current price level.
Overall SharesGrow Score: 19/100 with 0/7 criteria passed.
SharesGrow 7-Criteria Score
✗
VALUE
10/100
Price-to-Earnings & upside
Proven by this page
✗
HEALTH
0/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — OPT
Valuation Multiples
P/E (TTM)0.0
Forward P/E113.7
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio13,609.70
EV/EBITDA0.0
Per Share Data
EPS (TTM)$0.00
Forward EPS (Est.)$0.03
Book Value / Share$0.00
Revenue / Share$0.00
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Forward Earnings Yield0.88%
Dividend Yield0.00%
Analyst Target$2.00 (-41.3%)
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$-0.30 |
$0.00 |
$-6.51M |
- |
| 2017 |
$-0.27 |
$0.00 |
$-6.19M |
- |
| 2018 |
$-0.58 |
$0.00 |
$-16.9M |
- |
| 2019 |
$-0.72 |
$112.5K |
$-20.91M |
-18587.2% |
| 2020 |
$-0.49 |
$145.9K |
$-16.12M |
-11047% |
| 2021 |
$-1.44 |
$91.98K |
$-60.79M |
-66087.6% |
| 2022 |
$-2.72 |
$125.05K |
$-127.99M |
-102353.7% |
| 2023 |
$-3.60 |
$161.16K |
$-211.88M |
-131469.8% |
| 2024 |
$-22.16 |
$124.67K |
$-220.24M |
-176665.7% |
| 2025 |
$0.00 |
$38.36K |
$-250M |
-651771.5% |
